Catalyst Wire Dossier Catalyst Wire Dossier

anti-PCSK9 therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for anti-PCSK9 therapy, covering 2024-04-24 to 2024-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Bempedoic Acid in Association With Anti-PCSK9 and Ezetimibe in Statin-intolerant Patients [Phase 4]

See pricing